Atrys Health S.A.
ATRY
Overview
Corporate Details
- ISIN(s):
- ES0105148003
- LEI:
- 959800HHEE9W4TZA8627
- Country:
- Spain
- Address:
- Príncipe de Vergara 132 1, 28002 Madrid
- Website:
- https://www.atryshealth.com/en/
- Sector:
- Health Care
- Industry:
- Biotechnology
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-07 10:32 |
Investor Presentation
Atrys publica la presentación de resultados del primer trimestre del 2025
|
Spanish | 518.0 KB | |
| 2025-05-07 10:31 |
Board/Management Change
Atrys publica nota de prensa en relación con los resultados del primer trimestr…
|
Spanish | 161.0 KB | |
| 2025-05-07 08:51 |
Transaction in Own Shares
Atrys publica las operaciones realizadas por el proveedor de liquidez del perio…
|
Spanish | 232.5 KB | |
| 2025-05-07 08:32 |
Board/Management Change
Atrys publica nota de prensa en relación con los resultados del primer semestre…
|
Spanish | 161.0 KB | |
| 2025-05-07 08:29 |
General Meeting Notice
Atrys convoca la Junta General Ordinaria para el 12 de junio de 2025 (en primer…
|
Spanish | 222.0 KB | |
| 2025-05-07 08:22 |
Company Presentation
Atrys publica la presentación de resultados del primer cuatrimestre del 2025
|
Spanish | 518.0 KB | |
| 2025-04-30 15:41 |
Quarterly Report
Atrys anuncia la celebracion de un webcast para presentar los resultados del pr…
|
Spanish | 85.0 KB | |
| 2025-04-15 00:00 |
Directors' Dealings
Motivo de la notificación: Persona Estrechamente Vinculada
|
Spanish | 91.4 KB | |
| 2025-04-14 00:00 |
Directors' Dealings
Motivo de la notificación: Persona Estrechamente Vinculada
|
Spanish | 91.4 KB | |
| 2025-04-14 00:00 |
Directors' Dealings
Motivo de la notificación: Persona Estrechamente Vinculada
|
Spanish | 91.4 KB | |
| 2025-03-28 12:46 |
Declaration of Voting Results & Voting Rights Announcements
La sociedad remite el Informe Anual de Gobierno Corporativo del ejercicio 2024
|
Spanish | 404.6 KB | |
| 2025-03-28 08:35 |
Earnings Release
Atrys publica nota de prensa en relación con los resultados del ejercicio 2024
|
Spanish | 142.4 KB | |
| 2025-03-28 08:29 |
Investor Presentation
Atrys remite presentación de resultados del ejercicio 2024
|
Spanish | 2.9 MB | |
| 2025-03-28 00:00 |
Annual Report (ESEF)
|
Spanish | 13.5 MB | |
| 2025-03-17 14:47 |
Inside Information Statement
Atrys publica un comunicado en relación con noticas publicadas en prensa en el …
|
Spanish | 165.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Can-Fite BioPharma Ltd. | Israel | CANF | |
|
Cantargia | Sweden | CANTA | |
|
Captor Therapeutics S.A. | Poland | CTX | |
|
Carbiotix AB | Sweden | CRBX | |
|
Cellectis | France | ALCLS | |
|
CELLULAR GOODS PLC | United Kingdom | CBX | |
|
Celyad Oncology SA | Belgium | CYAD | |
|
Cereno Scientific AB | Sweden | CRNO | |
|
Cessatech A/S | Denmark | CESSA | |
|
CHOSA Oncology AB | Sweden | CHOSA |